Skip to main content
Dishman Carbogen Jan ’29

Dishman Carbogen Jan ’29

ISIN: INE385W07059

Key highlights

key_star
yield_img

Yield

10.90%

rating_img

Rating

A

min_invest_img

Min. invest

~₹ 74.47K

Interest

Principal

Maturity date

Seniority

Quarterly

Partial redemption by face value

20/01/2029

Senior (listed secured)

Dishman Carbogen Amcis Limited is a global pharmaceutical company that provides contract research, development, and manufacturing services for drug substances and specialty chemicals, supporting pharmaceutical and biotech clients from early-stage research to commercial production, with headquarters in Ahmedabad, India and operations across India, Europe, and Asia.

Key Management Personnel

Janmejay R. Vyas

Founder & Chairman

Secondary market activity
27 Jan 202613 Oct 2026

Last trade date

05 Oct '26

15 day traded volume

₹13.48 Cr

Avg. daily volume

₹90.00 L

Avg. daily trades

~3

Reflects all trades executed on NSE and BSE

Last updated on 13 Oct '26 at 4:00 AM

Yearly

*All values are in cr

Dishman Carbogen Amcis Ltd Hits Intraday High with 7.31% Surge on 3 Feb 2026•36 weeks ago

Dishman Carbogen Amcis Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.31% to touch a day’s high of Rs 233.5, significantly outperforming the broader market and its sector peers.

Samunnati raises Rs 2,300 Cr in FY25; expands lender base•79 weeks ago

Looking ahead, Samunnati has a debt pipeline exceeding Rs 600 crore for the first quarter of FY26, indicating continued momentum in its financing activity.

Other disclosures

Documents

Disclaimer: Bond details and related information displayed on this page are sourced from Deridata and other available sources and are provided for informational purposes. While BondScanner may review or validate certain information before displaying it, the information may be subject to change and should not be relied upon as the sole basis for any investment decision. Investors are advised to independently verify critical information from the relevant offer documents and other official sources before investing.

Source: Derivium Tradition India Securities Pvt Ltd.

Frequently asked questions

Dishman Carbogen Jan ’29Yield 10.90%

Units

Inv. amount

₹0

Exp. returns

₹0

Payout Schedule

By proceeding I agree to the T&C and Privacy Policy